These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8793587)

  • 1. Torsades de pointes induced by transesophageal atrial stimulation after administration of almokalant.
    Darpö B; Allared M; Edvardsson N
    Int J Cardiol; 1996 Mar; 53(3):311-3. PubMed ID: 8793587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
    Carlsson L; Abrahamsson C; Andersson B; Duker G; Schiller-Linhardt G
    Cardiovasc Res; 1993 Dec; 27(12):2186-93. PubMed ID: 8313427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study.
    Houltz B; Darpö B; Edvardsson N; Blomström P; Brachmann J; Crijns HJ; Jensen SM; Svernhage E; Vallin H; Swedberg K
    Pacing Clin Electrophysiol; 1998 May; 21(5):1044-57. PubMed ID: 9604236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of almokalant, a class III antiarrhythmic agent, on supraventricular, reentrant tachycardias. Almokalant Paroxysmal Supraventricular Tachycardia Study Group.
    Darpö B; Edvardsson N
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):499-508. PubMed ID: 9310280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: a comparison between almokalant and d-sotalol using the dog as its own control.
    Verduyn SC; Vos MA; van der Zande J; Kulcsàr A; Wellens HJ
    J Am Coll Cardiol; 1997 Nov; 30(6):1575-84. PubMed ID: 9362418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of almokalant, a selective potassium channel blocker, on the termination and inducibility of paroxysmal supraventricular tachycardias: a study in patients with Wolff-Parkinson-White syndrome and atrioventricular nodal reentrant tachycardia. Almokalant PSVT Study Group.
    Darpö B; Edvardsson N
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):198-206. PubMed ID: 7475043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V; Mermi J; Mewis C; Seipel L
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pauses after burst pacing provoke afterdepolarizations and torsades de pointes in a patient with long QT syndrome.
    Kirchhof P; Zellerhoff S; Mönnig G; Schulze-Bahr E
    Heart Rhythm; 2004 Dec; 1(6):720-3. PubMed ID: 15851245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of class III-induced proarrhythmias by flecainide in an animal model of the acquired long QT syndrome.
    Hallman K; Carlsson L
    Pharmacol Toxicol; 1995 Oct; 77(4):250-4. PubMed ID: 8577635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes.
    Farkas A; Leprán I; Papp JG
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):287-97. PubMed ID: 11791015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of sick sinus syndrome that developed torsades de pointes, pacing failure and sensing failure during administration of bepridil.
    Ohsawa M; Tanaka F; Kunugita F; Saito H; Nakamura M; Shiroto T; Hotta K; Chiba N; Hiramori K
    Jpn Heart J; 2003 Sep; 44(5):783-8. PubMed ID: 14587660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhythm anomalies related to delayed repolarization in vivo: influence of sarcolemmal Ca++ entry and intracellular Ca++ overload.
    Carlsson L; Drews L; Duker G
    J Pharmacol Exp Ther; 1996 Oct; 279(1):231-9. PubMed ID: 8858998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological, rate dependent, and autonomic effects of the class III antiarrhythmic almokalant after myocardial infarction in the pig.
    Tuininga YS; De Langen CD; Crijns HJ; Wiesfeld AC; Mook PH; Bel KJ; Lie KI
    Pacing Clin Electrophysiol; 1996 May; 19(5):802-10. PubMed ID: 8734747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torsades de pointes with Almokalant, a new class III antiarrhythmic drug.
    Wiesfeld AC; Crijns HJ; Bergstrand RH; Almgren O; Hillege HL; Lie KI
    Am Heart J; 1993 Oct; 126(4):1008-11. PubMed ID: 8213422
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torsades de pointes: electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities.
    Horowitz LN; Greenspan AM; Spielman SR; Josephson ME
    Circulation; 1981 May; 63(5):1120-8. PubMed ID: 7471373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lidocaine and nisoldipine attenuate almokalant-induced dispersion of repolarization and early afterdepolarizations in vitro.
    Abrahamsson C; Carlsson L; Duker G
    J Cardiovasc Electrophysiol; 1996 Nov; 7(11):1074-81. PubMed ID: 8930739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes?
    Medina-Ravell VA; Lankipalli RS; Yan GX; Antzelevitch C; Medina-Malpica NA; Medina-Malpica OA; Droogan C; Kowey PR
    Circulation; 2003 Feb; 107(5):740-6. PubMed ID: 12578878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.